Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Atypical cancer risk profile in carriers of Italian founder BRCA1 variant p.His1673del: Implications for classification and clinical management

Cancer Medicine(2024)10.1002/cam4.70114Source: DataRank Database

Atypical cancer risk profile in carriers of Italian founder BRCA1 variant p.His1673del: Implications for classification and clinical management is a research paper published in Cancer Medicine (2024). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)Impact (FWCI 1.18)OA: goldTopics (75)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (32)

Cristina Fortuño ORCID,Laura Caleca ORCID,Bing Feng ORCID,Courtney Carroll ORCID,Michael T. Parsons ORCID

Live enrichment

PubMed:39194334 PMC:PMC11350839 OpenAlex:https://openalex.org/W4401953763

National Institutes of Health

Grant: U24 5U24CA258058‐02

NCI NIH HHS

Grant: U24 CA258058

Fondazione AIRC per la ricerca sul cancro ETS

Grant: AIRC; IG22093

NHMRC

Grant: APP177524

Ministero della Salute

Grant: RC‐2023‐2778941/RC‐2024‐2790136

Ministero della Salute

Grant: RC-2023-2778941/RC-2024-2790136

National Breast Cancer Foundation

Grant: IIRS-21-102

NIH HHS

Grant: U24 5U24CA258058-02

National Breast Cancer Foundation

Grant: IIRS‐21‐102

National Institutes of Health

Grant: 5U24CA258058-02

BRCA1/2 and Hereditary Breast, Ovarian and Pancreatic (HBOP) Cancer Variant Curation Expert Panels

National Institutes of Health

Grant: 5U24CA258058-03

BRCA1/2 and Hereditary Breast, Ovarian and Pancreatic (HBOP) Cancer Variant Curation Expert Panels

FWCI

1.18

Citation Percentile

0.8%

Citation Trend

2024

2025

goldLicense: cc-by

journalhttps://doi.org/10.1002/cam4.70114

publisherhttps://doi.org/10.1002/cam4.70114

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39194334

repositoryhttps://onlinelibrary.wiley.com/doi/10.1002/cam4.70114?msockid=1c6e660d8aa06b0519cf72ff8bcc6ab4

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11350839

Fields of Study

BRCA gene mutations in cancerBreast Cancer Treatment StudiesMale Breast Health Studies03 medical and health sciences0303 health sciencesHumansFemaleItalyBRCA1 ProteinGenetic Predisposition to DiseaseMiddle AgedPenetranceAdultOvarian NeoplasmsPedigreeBreast NeoplasmsAgedHeterozygoteFounder EffectRisk FactorsCarrier Proteins

MeSH Terms

AdultAgedBreast NeoplasmsCarrier ProteinsFemaleHeterozygoteHumansItalyMaleMiddle AgedOvarian NeoplasmsPedigreeRisk FactorsFounder EffectBRCA1 ProteinPenetranceGenetic Predisposition to Disease

Keywords

PenetranceOvarian cancerBreast cancerCancerPathogenicityGenetic counselingInternal medicineOncologyBiologyMedicineGeneticsGenePhenotypeClassificationBRCA1Cancer RiskClinical ManagementUterine CancerAdultHeterozygoteBreast NeoplasmsRisk FactorsHumansGenetic Predisposition to DiseaseRC254-282AgedOvarian NeoplasmsBRCA1; breast cancer; cancer risk; classification; clinical management; ovarian cancer; penetrance; uterine cancerBRCA1 ProteinNeoplasms. Tumors. Oncology. Including cancer and carcinogensMiddle AgedFounder EffectPedigreeItalyFemaleCarrier ProteinsResearch Article

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being